Detalhe da pesquisa
1.
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
N Engl J Med
; 388(4): 319-332, 2023 01 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36511784
2.
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment.
Future Oncol
; 20(12): 717-726, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38088119
3.
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(12): 1423-1433, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37944541
4.
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Br J Haematol
; 202(1): 40-47, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36971061
5.
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Ann Hematol
; 102(4): 811-817, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36847805
6.
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(8): 1031-1043, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35810754
7.
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trial.
Haematologica
; 107(9): 2108-2120, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35021599
8.
Effects of Sulforaphane-Induced Cell Death upon Repeated Passage of Either P-Glycoprotein-Negative or P-Glycoprotein-Positive L1210 Cell Variants.
Int J Mol Sci
; 23(18)2022 Sep 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36142752
9.
[Options and limits of arthroscopic treatment of joint empyema]. / Optionen und Grenzen der arthroskopischen Behandlung von Gelenkempyemen.
Unfallchirurg
; 125(1): 26-32, 2022 Jan.
Artigo
Alemão
| MEDLINE | ID: mdl-34874471
10.
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
Br J Haematol
; 193(1): 133-137, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33280081
11.
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group.
Br J Haematol
; 193(4): 769-778, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33618437
12.
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Eur J Clin Invest
; 51(4): e13421, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33022756
13.
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Ann Hematol
; 100(7): 1733-1742, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34018029
14.
Optimisation of Recombinant Myrosinase Production in Pichia pastoris.
Int J Mol Sci
; 22(7)2021 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33916093
15.
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion.
Haematologica
; 106(9): 2354-2363, 2020 10 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33054121
16.
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
Hematol Oncol
; 38(4): 509-516, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32400885
17.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32096887
18.
Functional dissection of gamma-aminobutyric acid metabolism in Neurospora crassa.
Gen Physiol Biophys
; 39(3): 205-218, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32525814
19.
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 20(1): 43-56, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30522969
20.
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
Ann Hematol
; 98(12): 2749-2760, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31745601